What Arkin Capital does

Arkin Capital (legal entity M. Arkin (1999) Ltd.) is an Israeli private multi-asset investment manager founded in 2009 by Mori Arkin and headquartered in Herzliya. The firm manages over $2 billion in assets under management across four specialized investment arms: Arkin Health (life-sciences VC via Arkin Bio, healthcare hedge funds via Sphera Health, and digital-health VC via A-Squared Ventures), Arkin Equity (Israeli public markets via the Idea Hedge Fund, private equity via Arkin Private Equity, and venture-building via Arkin Foundry), Arkin Tech (early-stage diversified technology), and Arkin Real Estate (North American and European residential, commercial, and industrial properties). The firm invests across the full capital stack from seed and Series A (Arkin Bio Ventures, Arkin Tech, Arkin Foundry) through growth and late-stage (Arkin Bio Capital, Arkin Opportunity) and into public equities and hedge fund strategies, with named portfolio companies including DigitalOcean, Cellebrite, Keros Therapeutics, HI-Bio, Crossbow Therapeutics, Nocion Therapeutics, TopGum, and Fu-Gen.

Arkin generates revenue through three primary streams: (i) annual management fees, typically ~2% on committed/invested capital across its closed-end fund vehicles, providing a recurring base; (ii) performance fees / carried interest, typically ~20% above hurdle rates, earned on exits such as the HI-Bio acquisition by Biogen for up to $1.8 billion; and (iii) direct investment returns on proprietary capital co-invested alongside fund capital. The firm is privately held by the Arkin family (Mori Arkin as Founder & Chairman, Nir Arkin as CEO), with institutional backing from named Israeli insurance and pension LPs (Menora, Harel, Phoenix, Migdal, Clal, Leumi, Yalin Lapidot, Meitav, and others), and operates with a lean team of approximately 20 employees including six Managing Partners and principals with PhD-level scientific training. The most recent strategic step was the January 2026 close of a $100 million third early-stage biotech fund, alongside parallel 2025 launches of A-Squared Ventures (digital health) and the IDEA Bond Hedge Fund.

Name

Arkin Capital

Legal name

M. Arkin (1999) Ltd.

Website

https://arkin-capital.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Arkin Capital is a Herzliya-based private multi-asset manager founded in 2009 by Mori Arkin, managing over $2 billion across life-sciences VC, healthcare hedge funds, Israeli equities, early-stage tech, and global real estate for Israeli institutional LPs.

Ownership category

akta.pro rank

Product category

Multi-Asset Investment Management

NAICS

Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282), Investors, Nec (6799), Real Estate Dealers (For Their Own Account) (6532)

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

akta.pro secondary industries

Advisory Portfolio Management (Non-Discretionary) (FSAAABAD), Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN), Portfolio Construction & Asset Allocation Advisory (FSAEAAAC)

Keywords

• Venture capital management
• Private equity funds
• Hedge fund management
• Asset management services
• Life sciences investment

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Management Fees: Annual management fees charged on assets under management as a percentage of committed capital, typical for VC/PE fund structures. Provides steady recurring revenue base.
2. Performance Fees (Carried Interest): Carried interest earned on investment returns above hurdle rates, typically 20% of profits. Represents the primary value creation incentive for fund managers.
3. Investment Returns: Direct returns on proprietary capital investments alongside managed fund capital. Returns realized through exits via IPOs, acquisitions, and secondary transactions.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Arkin Capital is a multi-asset investment manager managing over $2 billion across venture capital, private equity, and hedge fund strategies. The firm operates four main investment arms — Arkin Health (biotech and healthcare), Arkin Equity (private equity and Israeli public markets), Arkin Tech (early-stage technology), and Arkin Real Estate — providing institutional investors with access to specialized fund vehicles.

Product overview

Arkin Capital is a multi-asset investment manager with over $2 billion under management across four main investment arms. Arkin Health includes Arkin Bio (life sciences VC), Sphera Health (healthcare hedge funds), and A-Squared Ventures (digital health). Arkin Equity encompasses the Idea Hedge Fund (Israeli equities), Arkin Private Equity, and Arkin Foundry. Arkin Tech invests in diversified technology early-stage companies, while Arkin Real Estate manages investments across global real estate markets. The company was established in 2009 by Mori Arkin and supports portfolio companies from early to late stages.

Differentiator

Problem solved

Functional benefit

Brands

• Arkin Bio Ventures: Early-stage biotech venture fund focusing on pre-clinical and clinical-stage biotech companies
• Arkin Bio Capital
• Sphera Global Healthcare
• Sphera Biotech
• Idea Hedge Fund

Products and services

• Arkin Bio A leading global life sciences VC offering early-stage biotech investments through Arkin Bio Ventures and late-stage biotech investments through Arkin Bio Capital, for institutional investors seeking biotech exposure.
• Sphera Health Israel's first and leading healthcare hedge fund, partnering with Sphera Funds Management. Includes Sphera Global Healthcare (long/short equity strategy) and Sphera Biotech (focused on small and mid-cap biotech companies), for investors seeking healthcare-focused hedge fund returns.
• A-Squared Ventures Digital health investment vehicle within Arkin Health, focusing on digital health startups alongside Arkin Bio's life sciences portfolio.
• Idea Hedge Fund Hedge fund focused on small and medium-sized Israeli and Israeli-related companies employing a long-bias strategy using fundamental analysis to identify underpriced stocks and debt.
• Arkin Private Equity Since 2019, invests in high-growth companies in partnership with leading capital market players. Focuses on building value through strategic and long-term investments in companies such as TopGum, EverPhone, and Cellebrite.
• Arkin Foundry Transforms innovative ideas into successful companies by leveraging deep industry knowledge and network. Focuses on opportunities particularly within Israel, supporting ventures from seeding to anchoring stage.
• Arkin Tech Invests in diversified technologies, partnering primarily with visionary early-stage companies. Has made over 30 investments including DigitalOcean, Lendbuzz, HoneyBook, Via, and Percepto.
• Arkin Real Estate Leading investor in global real estate opportunities, active across North America and Europe via various vehicles and investment strategies in residential, commercial, and industrial markets.

Quantifiable outcome

• $100M raised for third biotech fund demonstrating LP confidence
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Fu-GencoreStrategic or Co-development Partner · 1 January 2024Arkin Capital partnered with Fu-Gen, a Nordic renewable energy developer, for renewable energy project development. The partnership focuses on developing utility-scale solar and wind projects in the Nordic region. Fu-Gen has developed over 215 MW of operational renewable energy capacity with an additional 9 GW in development pipeline. The collaboration represents a strategic expansion of Arkin's renewable energy investment activities into European markets.

Scale indicators5 records

Recent moves17 records

Expansion highlights5 records

Direct peers

• TLV Partners: Israel-focused early-stage venture firm led by former Yahoo and AOL executives. Comparable as an Israeli VC with strong ecosystem relationships and early-stage focus.
• Jerusalem Venture Partners (JVP): Israel-based VC firm with multiple funds spanning early-stage to growth-stage investments across deep tech, cybersecurity, and digital health. Comparable in Israeli ecosystem focus and multi-fund platform structure.
• Pontifax: Israel-based healthcare-dedicated venture capital firm with multiple funds covering therapeutics, medical devices, and digital health. Direct competitor in the Israeli biotech VC space.
• Elron Electronic Industries: Israeli holding and venture capital firm focused on technology and healthcare investments. Comparable as an Israeli multi-fund platform with similar mix of early-stage tech and biotech holdings.
• Accelmed: Israel-based healthcare private equity firm focused on medical devices and healthtech. Comparable as an Israeli-domiciled healthcare-focused investment manager with multi-fund structure.
• Pitango Venture Capital: Israel's largest venture capital firm managing multiple funds across tech, healthcare, and growth stages. Directly comparable as an Israeli multi-stage, multi-sector asset manager with similar institutional LP backing.
• aMoon Fund: Israeli healthtech and biotech venture fund with both growth and early-stage vehicles. Comparable as a specialized Israeli healthcare-focused VC platform with institutional backing.
• OurCrowd: Israel-based global venture investment platform with multiple sector-focused funds including healthcare. Comparable as a multi-asset Israeli investment manager with similar LP base among Israeli institutional and individual investors.

Broad incumbents

• Sequoia Capital: Global multi-stage venture and growth capital firm with broad sector exposure. Comparable as a multi-strategy asset manager but operates at much larger scale across global geographies.
• General Atlantic: Global growth equity firm investing across sectors and stages. Comparable as a multi-strategy growth investor, though focused on larger checks and broader geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arkin-capial

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arkin Capital